1. Home
  2. NTST vs AMLX Comparison

NTST vs AMLX Comparison

Compare NTST & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$20.57

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.71

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
AMLX
Founded
2019
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
NTST
AMLX
Price
$20.57
$14.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
9
Target Price
$22.02
$21.56
AVG Volume (30 Days)
1.2M
1.0M
Earning Date
04-20-2026
05-07-2026
Dividend Yield
4.28%
N/A
EPS Growth
150.00
65.46
EPS
0.06
N/A
Revenue
$195,006,000.00
$380,786,000.00
Revenue This Year
$19.03
N/A
Revenue Next Year
$16.25
N/A
P/E Ratio
$345.08
N/A
Revenue Growth
19.79
1612.94
52 Week Low
$15.37
$4.64
52 Week High
$21.30
$18.61

Technical Indicators

Market Signals
Indicator
NTST
AMLX
Relative Strength Index (RSI) 54.73 39.18
Support Level $19.98 $13.57
Resistance Level $21.24 $15.37
Average True Range (ATR) 0.33 0.85
MACD -0.02 -0.32
Stochastic Oscillator 66.67 11.17

Price Performance

Historical Comparison
NTST
AMLX

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: